FDA Delays Approval of Replimune’s Melanoma Therapy Despite Promising Trial Results
For now, the FDA has denied approval today of a new melanoma treatment developed by Replimune. The company’s lead drug...
results
ViiV Healthcare shares results from trial of HIV treatment regimes
The DOLCE study evaluated the efficacy and safety of Dovato in around 230 antiretroviral treatment-naïve individuals with advanced HIV. Credit:...
